Adjusted comparison of teclistamab versus physician's choice of therapy in the long-term follow-up of daratumumab trials in patients with triple-class exposed relapsed or refractory multiple myeloma

被引：0

作者：

Mateos, Maria-Victoria ^{[1
]}

Chari, Ajai ^{[2
]}

Usmani, Saad ^{[3
]}

Goldschmidt, Hartmut ^{[4
]}

Weisel, Katja ^{[5
]}

Qi, Keqin ^{[6
]}

Londhe, Anil ^{[6
]}

Nair, Sandhya ^{[7
]}

Lin, Xiwu ^{[8
]}

Pei, Lixia ^{[9
]}

Ammann, Eric ^{[10
]}

Kobos, Rachel ^{[9
]}

Smit, Jennifer ^{[11
]}

Parekh, Trilok ^{[12
]}

Marshall, Alexander ^{[10
]}

Slavcev, Mary ^{[10
]}

Moreau, Philippe ^{[13
]}

机构：

[1] Univ Hosp Salamanca, CIC, IBMCC, Salamanca, Spain

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Univ Hosp Heidelberg, Internal Med & Natl Ctr Tumor Dis NCT 5, Heidelberg, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Sect Pneumol, Dept Oncol Hematol & Bone Marrow Transplant, Hamburg, Germany

[6] Janssen Res & Dev, Titusville, NJ USA

[7] Janssen Pharmaceut NV, Beerse, Belgium

[8] Janssen Global Serv, Horsham, PA USA

[9] Janssen Res & Dev, Raritan, NJ USA

[10] Janssen Global Serv, Raritan, NJ USA

[11] Janssen Res & Dev, Spring House, PA USA

[12] Janssen Res & Dev, Bridgewater, NJ USA

[13] Univ Hosp Hotel Dieu, Dept Hematol, Nantes, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-281

引用

页码：S192 / S193

页数：2